» Articles » PMID: 21070478

Encapsulated Follicular Thyroid Tumor with Equivocal Nuclear Changes, So-called Well-differentiated Tumor of Uncertain Malignant Potential: a Morphological, Immunohistochemical, and Molecular Appraisal

Overview
Journal Cancer Sci
Specialty Oncology
Date 2010 Nov 13
PMID 21070478
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

There is a continuous debate regarding the classification of thyroid follicular lesions and the term "well-differentiated tumor of uncertain malignant potential (WDT-UMP)" was recently introduced to cover this problematic spectrum of tumors. The objective of this study was to reappraise WDT-UMP using morphological, immunochemical, and molecular analysis and to shed more light on encapsulated thyroid follicular-patterned tumors. A total of 30 cases of WDT-UMP with equivocal papillary thyroid carcinoma-type nuclear changes (PTC-N) or focal unequivocal PTC-N were examined. As a control, follicular adenoma (n = 29), follicular carcinoma (n = 8), hyalinizing trabecular adenoma (n = 5), and PTC (n = 48) were included. HBME-1, cytokeratin 19, and galectin-3 were positive in 12 (40.0%), 10 (33.3%) and 11 (36.7%) cases of WDT-UMP, respectively. According to the positivity of those markers, significant differences were obtained between WDT-UMP and PTC encapsulated common type (P = 0.028, 0.010, and 0.004, respectively), infiltrative follicular variant (P = 0.020, 0.026, and 0.008, respectively), and infiltrative common type (P = 0.004, 0.001, and 0.005, respectively), but not between WDT-UMP and follicular adenoma or follicular carcinoma. BRAF(V600E) mutation was absent but RET/PTC1 rearrangement was found in only two (6.7%) cases of WDT-UMP. None of the 20 patients with WDT-UMP developed recurrence, with an average follow-up of 80 months. These findings indicate that WDT-UMP has a favorable outcome and is distinct from PTC in morphological, immunohistochemical, and molecular characteristics. We propose that WDT-UMP should be classified as "well-differentiated tumor with uncertain behavior".

Citing Articles

WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.

Goswami P, Patel T, Dave R, Singh G, Singh A, Kalonia T J Med Life. 2024; 17(1):15-23.

PMID: 38737660 PMC: 11080517. DOI: 10.25122/jml-2023-0270.


The Asian Thyroid Working Group, from 2017 to 2023.

Kakudo K, Jung C, Liu Z, Hirokawa M, Bychkov A, Vuong H J Pathol Transl Med. 2023; 57(6):289-304.

PMID: 37981725 PMC: 10660359. DOI: 10.4132/jptm.2023.10.04.


Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.

Chen D, Rob F, Mukherjee R, Giordano T, Haymart M, Banerjee M J Clin Endocrinol Metab. 2022; 107(10):e4072-e4077.

PMID: 35918064 PMC: 9516041. DOI: 10.1210/clinem/dgac466.


The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges.

Belousov P Biomedicines. 2022; 10(2).

PMID: 35203677 PMC: 8962333. DOI: 10.3390/biomedicines10020468.


Different Threshold of Malignancy for -like Thyroid Tumors Causes Significant Differences in Thyroid Nodule Practice.

Kakudo K Cancers (Basel). 2022; 14(3).

PMID: 35159081 PMC: 8834283. DOI: 10.3390/cancers14030812.


References
1.
Mai K, Yazdi H, PERKINS D, Commons A, Thomas J . Papillary thyroid carcinoma and related thyroid neoplastic lesions: a light microscopic study with emphasis on nuclear changes. Tumori. 2000; 86(3):238-49. DOI: 10.1177/030089160008600312. View

2.
Rosai J . The encapsulated follicular variant of papillary thyroid carcinoma: back to the drawing board. Endocr Pathol. 2010; 21(1):7-11. DOI: 10.1007/s12022-009-9103-1. View

3.
Asioli S, Erickson L, Lloyd R . Solid cell nests in Hashimoto's thyroiditis sharing features with papillary thyroid microcarcinoma. Endocr Pathol. 2009; 20(4):197-203. DOI: 10.1007/s12022-009-9095-x. View

4.
Papotti M, Rodriguez J, De Pompa R, Bartolazzi A, Rosai J . Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol. 2004; 18(4):541-6. DOI: 10.1038/modpathol.3800321. View

5.
Cameselle-Teijeiro J, Chan J . Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?. Mod Pathol. 1999; 12(4):400-11. View